Cargando…

Evinacumab – The new kid on the block. Is it important for cardiovascular prevention?

Detalles Bibliográficos
Autores principales:	Surma, Stanisław, Romańczyk, Monika, Filipiak, Krzysztof J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Invited Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710419/ https://www.ncbi.nlm.nih.gov/pubmed/34988554 http://dx.doi.org/10.1016/j.ijcrp.2021.200107

Ejemplares similares

Colchicine — From rheumatology to the new kid on the block: Coronary syndromes and COVID-19
por: Surma, Stanisław, et al.
Publicado: (2023)

Is colchicine the holy grail for treating inflammation and reducing cardiovascular risk?
por: Filipiak, Krzysztof J., et al.
Publicado: (2021)

Ranolazine - could an antianginal drug be used in stroke prevention?
por: Surma, Stanisław, et al.
Publicado: (2022)

Angiopoietin-like proteins inhibitors: New horizons in the treatment of atherogenic dyslipidemia and familial hypercholesterolemia
por: Surma, Stanisław, et al.
Publicado: (2023)

Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia
por: Sosnowska, Bożena, et al.
Publicado: (2022)

Heart Failure—Do We Need New Drugs or Have Them Already? A Case of Coenzyme Q10
por: Filipiak, Krzysztof J., et al.
Publicado: (2022)

Coffee and cardiac arrhythmias: Up-date review of the literature and clinical studies
por: Surma, Stanisław, et al.
Publicado: (2023)

What Is or What Is Not a Risk Factor for Arterial Hypertension? Not Hamlet, but Medical Students Answer That Question
por: Sobierajski, Tomasz, et al.
Publicado: (2022)

Commentary: AADI: New kid on the block
por: Pathak-Ray, Vanita
Publicado: (2018)

Periodontitis, Blood Pressure, and the Risk and Control of Arterial Hypertension: Epidemiological, Clinical, and Pathophysiological Aspects—Review of the Literature and Clinical Trials
por: Surma, Stanisław, et al.
Publicado: (2021)

LDL-cholesterol targets as Achilles’ heel of 2020 ISH guidelines
por: Filipiak, Krzysztof J.
Publicado: (2021)

GPR40 Modulators: New Kid on the Block
por: Basu, Ananda, et al.
Publicado: (2013)

Assessment of the Effect of A-PRF Application during the Surgical Extraction of Third Molars on Healing and the Concentration of C-Reactive Protein
por: Nowak, Jacek M., et al.
Publicado: (2021)

Unexpected Relationships: Periodontal Diseases: Atherosclerosis–Plaque Destabilization? From the Teeth to a Coronary Event
por: Czerniuk, Maciej R., et al.
Publicado: (2022)

Deoxysphingolipids: β-Cell, Beware of These New Kids on the Block
por: Kowluru, Anjaneyulu
Publicado: (2014)

Fungal microbiome and multiple sclerosis: The not-so-new kid on the block
por: Mangalam, Ashutosh K.
Publicado: (2021)

Treatment of Homozygous Familial Hypercholesterolemia With Evinacumab
por: Jeraj, Natasha, et al.
Publicado: (2021)

Whole Body Cryotherapy and Hyperbaric Oxygen Treatment: New Biological Treatment of Depression? A Systematic Review
por: Krzystanek, Marek, et al.
Publicado: (2021)

Possible Antidepressant Effects of Memantine—Systematic Review with a Case Study
por: Krzystanek, Marek, et al.
Publicado: (2021)

New Kid on the Block: A Role for the Na/Ca Exchanger in Odor Transduction
por: Dionne, Vincent E.
Publicado: (1998)

The Chromosomal Conformation Signature: A New Kid on the Block in ALS Biomarker Research?
por: Poesen, Koen
Publicado: (2018)

Omicron variant of SARS-CoV-2 – A new kid on the block
por: Husain, Uneza, et al.
Publicado: (2022)

Management of Familial Hypercholesterolemia with Special Emphasis on Evinacumab
por: Krzemińska, Julia, et al.
Publicado: (2022)

The Effect of a Vegan Diet on the Cardiovascular System
por: Koutentakis, Michail, et al.
Publicado: (2023)

The Global Pandemic as a Life-Changer? Medical, Psychological, or Self Help during COVID-19 Pandemic: A Cross-Sectional Representative Study
por: Sobierajski, Tomasz, et al.
Publicado: (2023)

Inflammation and autoimmunity in atherosclerosis
por: Surma, Stanislaw, et al.
Publicado: (2022)

New Kid on the Block
por: Reinheckel, Thomas
Publicado: (2017)

New kid on the block
Publicado: (2008)

New kids on the block: emerging oleaginous yeast of biotechnological importance
por: Yaguchi, Allison, et al.
Publicado: (2017)

Longer-Term Efficacy and Safety of Evinacumab in Patients With Refractory Hypercholesterolemia
por: Rosenson, Robert S., et al.
Publicado: (2023)

Knowledge of Primary Care Patients Living in the Urban Areas about Risk Factors of Arterial Hypertension
por: Sobierajski, Tomasz, et al.
Publicado: (2023)

Treatment of Homozygous Familial Hypercholesterolemia With ANGPTL3 Inhibitor, Evinacumab
por: Shamsudeen, Isabel, et al.
Publicado: (2023)

The importance of sexual function in men with spinal cord injuries
por: Kovac, Jason R, et al.
Publicado: (2016)

Population pharmacokinetics and exposure–response modeling for evinacumab in homozygous familial hypercholesterolemia
por: Pu, Xia, et al.
Publicado: (2021)

Systemic lupus erythematosus and cardiovascular disease
por: Ruilope, Luis M., et al.
Publicado: (2020)

NAADP Signaling: New Kids on the Block
por: Guse, Andreas H.
Publicado: (2022)

BTK, the new kid on the (oncology) block?
por: Grassilli, Emanuela, et al.
Publicado: (2022)

The New Kid on the Block: Mass Photometry
por: Graciani, Guillaume, et al.
Publicado: (2023)

Technology and cardiovascular diseases in the era of COVID‐19
por: Harky, Amer, et al.
Publicado: (2020)

IRON METABOLISM AND AUTOPHAGY: A POORLY EXPLORED RELATIONSHIP THAT HAS IMPORTANT CONSEQUENCES FOR HEALTH AND DISEASE
por: KRISHAN, SUKRITI, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5sp64osbg1c7pg9593re6aje1b